Skip to main content
. 2022 Nov 15;9(7):724–730. doi: 10.1093/ehjqcco/qcac074

Table 2 .

Procedural details and complications.

Parameter Conventional (n = 57)* ASTRID-AS (n = 25) P value
Prosthesis type Navitor 4 (7.0%) 2 (8.0%) 0.904
Portico 18 (31.6%) 6 (24.0%)
Sapien 3 26 (45.6%) 11 (44.0%)
Sapien S3 ultra 9 (15.8%) 6 (24.0%)
Pre-dilatation 26 (45.6%) 8 (32.0%) 0.249
Further valve intervention 2 (3.5%) 2 (8.0%) 0.582
General anaesthesia 2 (3.5%) 0 (0.0%) 1.000
Vasopressor/inotrope use 4 (7.0%) 1 (4.0%) 1.000
Contrast administered (ml) 213 (191–242) 199 (167–221) 0.058
Pacemaker 4 (7.0%) 3 (12.0%) 0.670
Stroke 0 0 n/a
Major vascular complication 1 (1.8%) 0 (0.0%) 1.000
Minor vascular complication 4 (7.0%) 2 (8.0%) 1.000
Major bleeding 1 (1.8%) 2 (8.0%) 0.219
Minor bleeding 4 (7.0%) 2 (8.0%) 1.000
Decrease in haemoglobin (g/dL) 1.5 ± 1.3 1.3 ± 1.1 0.579
Red Cell transfusion 5 (8.6%) 2 (8.0%) 1.000

*One patient in the conventional cohort died in hospital before TAVI. Contrast administered is the total volume of contrast used from CT angiography and TAVI.